Humanoid Global Holdings Corp
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$16.42M
Humanoid Global Holdings Corp. is focusing on e-sports, artificial intelligence (AI), blockchain, and Web3 sectors. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2007-03-07. The Company’s objective is to generate income and achieve long term capital appreciation through investments focused on e-sports, artificial intelligence (AI), blockchain, and Web3 sectors. The Company, through its subsidiary, Rosey Inc., offers a series of intellectual property, including certain assets relating to AI and an AI-Powered Command Center that encompasses a series of tools tailored for the enhancement of productivity, creativity, and both personal and professional development. The Company, through Longevity AI Inc., is focused on leveraging science and technology to enhance global health by providing a platform for real-time patient health monitoring, designed for hospitals and medical organizations. The company owns and operates technology that connects patients to cutting-edge clinical treatments around biomarkers, longevity, anti-aging protocols and the central nervous system.
Humanoid Global Holdings Corp. is focusing on e-sports, artificial intelligence (AI), blockchain, and Web3 sectors. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2007-03-07. The Company’s objective is to generate income and achieve long term capital appreciation through investments focused on e-sports, artificial intelligence (AI), blockchain, and Web3 sectors. The Company, through its subsidiary, Rosey Inc., offers a series of intellectual property, including certain assets relating to AI and an AI-Powered Command Center that encompasses a series of tools tailored for the enhancement of productivity, creativity, and both personal and professional development. The Company, through Longevity AI Inc., is focused on leveraging science and technology to enhance global health by providing a platform for real-time patient health monitoring, designed for hospitals and medical organizations. The company owns and operates technology that connects patients to cutting-edge clinical treatments around biomarkers, longevity, anti-aging protocols and the central nervous system.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.